Epibone, Inc.
New York, NY
- UEI
- LVKJHJJ9MVQ6
- CAGE
- 6ZWJ7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 531 Main St #1515, New York, NY 10044, USA
- Website
- epibone.com
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Regenerating warfighter mobility with EB-OC- a next-generation living osteochondral graft to treat combat-acquired… | Air Force Research Laboratory | $1,249,964 | |
| Next-generation craniofacial surgery: validating epibone EB-CMF regenerative bone grafts for use in the maxilla | Air Force Research Laboratory | $1,249,628 | |
| Solution to provide cartilage replacement for long-term and progressive usage | Air Force Research Laboratory | $74,481 | |
| Epibone: solution to provide bone reconstruction due to battlefield injury | Air Force Research Laboratory | $74,871 | |
| Award of DHA 2017.1(b) sbir phase II r & d contract to epibone, INC. IAW proposal H2-0367 for "injectable… | Medical Command | $999,921 |
About Epibone, Inc.
Epibone, Inc. is a corporate, for-profit organization registered in SAM.gov, specializing in advanced regenerative medicine and tissue engineering technologies located in Jersey City, New Jersey. The company focuses on developing innovative medical solutions, particularly personalized bone and tissue reconstruction techniques using patient-specific stem cell technologies. Epibone develops cutting-edge cellular cultivation methods for creating customized bone grafts and tissue engineering solutions, with a primary emphasis on medical applications for military personnel suffering from severe bone trauma.
Through federal contract awards, Epibone has consistently worked with the Air Force Research Laboratory (AFRL) on Small Business Innovation Research (SBIR) Program contracts. These contracts are specifically designed to support bone and cartilage reconstruction technologies, with three notable Phase I and Phase II awards totaling approximately $1,398,980. The contracts are all set aside for small businesses and focus on developing advanced medical solutions for military personnel, including projects like "Next-Generation Craniofacial Surgery: Validating Epibone EB-CMF Regenerative Bone Grafts for Use in the Maxilla" and "Solution to Provide Cartilage Replacement for Long-Term and Progressive Usage". Each contract is a firm-fixed-price purchase order with completion dates ranging from November 2024 to February 2027, demonstrating the company's ongoing commitment to developing innovative medical reconstruction technologies.
Regarding federal grant sub-awards, Epibone has received awards focused on advancing tissue engineering infrastructure and capabilities. These sub-awards include a grant for "Tissue Foundry Development for Patient-Specific Autologous Tissue Engineered Bone Graft" awarded on October 4, 2021, and another for "Advancing the Storage and Transport of Engineered Tissues" awarded on September 13, 2021. These grants indicate the company's broader research objectives in developing sophisticated techniques for creating, storing, and transporting engineered tissue solutions. The sub-awards suggest Epibone is working to improve the technological foundations of tissue engineering, with a particular emphasis on creating more efficient and reliable methods for developing patient-specific biological reconstruction technologies.
Quick answers
What is Epibone, Inc.'s UEI?
Epibone, Inc.'s Unique Entity ID (UEI) in SAM.gov is LVKJHJJ9MVQ6.
What is Epibone, Inc.'s CAGE code?
Epibone, Inc.'s CAGE code is 6ZWJ7.
What is Epibone, Inc.'s primary NAICS code?
Epibone, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Epibone, Inc. located?
Epibone, Inc.'s physical address in SAM.gov is 531 Main St #1515, New York, NY 10044, USA.
Is Epibone, Inc. registered in SAM.gov?
Yes. Epibone, Inc.'s SAM.gov registration is active through August 26, 2027.
What is Epibone, Inc.'s most recent federal award?
Epibone, Inc.'s most recent federal contract award is Regenerating warfighter mobility with EB-OC- a next-generation living osteochondral graft to treat combat-acquired… (FA864925P0473), from Air Force Research Laboratory, on August 28, 2025.
On GovTribe
See Epibone, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors